MedTrace Logo

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

NCT05706220 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-05-16

No results posted yet for this study

Summary

This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.

Conditions

Interventions

DIAGNOSTIC_TEST

Eye tracking

Eye tracker will be used to evaluate eye movements

DIAGNOSTIC_TEST

Microperimetry

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

DIAGNOSTIC_TEST

Optical coherence tomography (OCT)

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

DIAGNOSTIC_TEST

Visual processing speed test

Visual processing speed test will be used for assessing subject visual stimulus search and reach times. Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Sponsors & Collaborators

  • Fundación Eugenio Rodríguez Pascual

    collaborator UNKNOWN

  • Hospital del Rio Hortega

    collaborator OTHER

  • Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05706220 on ClinicalTrials.gov